| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biomedical Research Institute, Department of Biological Sciences, University of Warwick, Coventry, United Kingdom CV4 7AL
Address all correspondence and requests for reprints to: Dr. Harpal S. Randeva, Department of Biological Sciences, University of Warwick, Gibbet Hill Road, Coventry, United Kingdom CV4 7AL. E-mail: hrandeva{at}bio.warwick.ac.uk.
Orexin-A (OR-A) and OR-B are derived from a common 130-amino acid precursor peptide, prepro-OR, by proteolytic cleavage. Orexins orchestrate their actions by binding and activating two types of G protein-coupled receptors, OR-1 receptor (OX1R) and OR-2 receptor (OX2R). Besides playing a role in the regulation of feeding and energy homeostasis in rats, ORs appear to increase sexual arousal as well as copulatory performance in rats. Furthermore, OR-A and -B immunoreactivity has been detected in rat testis. In view of these findings we investigated the expression of OR receptors and their signaling characteristics in the human male reproductive system. Using RT-PCR analysis, we were able to demonstrate that both OX1R and OX2R are expressed in the testis, epididymis, penis, and seminal vesicle, whereas prepro-OR was expressed only in the epididymis and penis. Protein expression of both OR receptors in human testis was confirmed by Western blotting analysis, with apparent molecular masses of 50 kDa for OX1R and 40 kDa for OX2R. Immunofluorescent studies revealed staining for both OX1R and OX2R in Leydig cells, myoid cells of the seminiferous tubules, and Sertoli cells. To test the ability of ORs to activate testicular phospholipase C, we determined the effects of OR-A and OR-B on inositol trisphosphate production. When membranes from testicular biopsies were incubated with OR-A or OR-B, there was a rapid inositol trisphosphate turnover. This effect appeared to be dose dependent. These data provide a novel insight into the expression and signaling characteristics of OR receptors in the human male reproductive system and potentially further implicate these peptides, acting in an autocrine/paracrine manner, in the regulation of arousal mechanisms in humans.
This work was supported by the General Charities of City of Coventry.
E.K. and J.C. should be considered first coauthors by virtue of their equal contributions to the study.
Abbreviations: IP3, Inositol trisphosphate; OR, orexin; OX1R, orexin-1 receptor; OX2R, orexin-2 receptor; nNOS, neuronal NO synthase; NO, nitric oxide; NOS, NO synthase; PLC, phospholipase C; PMSF, phenylmethylsulfonylfluoride; SDS, sodium dodecyl sulfate; T, testosterone; TPMC, testicular peritubular myoid cell; UCN, urocortin.
This article has been cited by other articles:
 |
|
 |
|
  J. Wenzel, N. Grabinski, C. A. Knopp, A. Dendorfer, M. Ramanjaneya, H. S. Randeva, M. Ehrhart-Bornstein, P. Dominiak, and O. Johren Hypocretin/orexin increases the expression of steroidogenic enzymes in human adrenocortical NCI H295R cells Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2009; 297(5): R1601 - R1609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Silveyra, V. Lux-Lantos, and C. Libertun Both orexin receptors are expressed in rat ovaries and fluctuate with the estrous cycle: effects of orexin receptor antagonists on gonadotropins and ovulation Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E977 - E985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J E Digby, J Chen, J Y Tang, H Lehnert, R N Matthews, and H S Randeva Orexin receptor expression in human adipose tissue: effects of orexin-A and orexin-B. J. Endocrinol., October 1, 2006; 191(1): 129 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Voisin, A. E. Firar, V. Avondo, and M. Laburthe Orexin-Induced Apoptosis: The Key Role of the Seven-Transmembrane Domain Orexin Type 2 Receptor Endocrinology, October 1, 2006; 147(10): 4977 - 4984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Spinazzi, P. G. Andreis, G. P. Rossi, and G. G. Nussdorfer Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol. Rev., March 1, 2006; 58(1): 46 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ammoun, L. Johansson, M. E. Ekholm, T. Holmqvist, A. S. Danis, L. Korhonen, O. A. Sergeeva, H. L. Haas, K. E. O. Akerman, and J. P. Kukkonen OX1 Orexin Receptors Activate Extracellular Signal-Regulated Kinase in Chinese Hamster Ovary Cells via Multiple Mechanisms: The Role of Ca2+ Influx in OX1 Receptor Signaling Mol. Endocrinol., January 1, 2006; 20(1): 80 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Barreiro, R. Pineda, F. Gaytan, M. Archanco, M. A. Burrell, J. M. Castellano, H. Hakovirta, M. Nurmio, L. Pinilla, E. Aguilar, et al. Pattern of Orexin Expression and Direct Biological Actions of Orexin-A in Rat Testis Endocrinology, December 1, 2005; 146(12): 5164 - 5175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Holmqvist, L. Johansson, M. Ostman, S. Ammoun, K. E. O. Akerman, and J. P. Kukkonen OX1 Orexin Receptors Couple to Adenylyl Cyclase Regulation via Multiple Mechanisms J. Biol. Chem., February 25, 2005; 280(8): 6570 - 6579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen and H. S. Randeva Genomic Organization of Mouse Orexin Receptors: Characterization of Two Novel Tissue-Specific Splice Variants Mol. Endocrinol., November 1, 2004; 18(11): 2790 - 2804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Kok, F. Roelfsema, S. Overeem, G. J. Lammers, M. Frolich, A. E. Meinders, and H. Pijl Pulsatile LH release is diminished, whereas FSH secretion is normal, in hypocretin-deficient narcoleptic men Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E630 - E636. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
